Medicus Sciences Acquisition Corp.
MSAC
NASDAQ Capital Market10.17
USD
+0.01
- -
CIK
0001836517
ISIN
KYG5960S1084
CUSIP
G5960S108
Return %
Stock
S&P500
1Y
4.09
18.21
3Y
-3.14
63.29
5Y
-3.14
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jacob Jay Gottlieb
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 152 West 57th Street New York City NY United States of America 10019
- IPO Date
- Apr 5, 2021
- CIK
- 0001836517
- Website
- medicusspac.com
- Similar Companies
- Business
- Medicus Sciences Acquisition Corp. (MSAC) operates as a blank check company whose principal business activity is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Incorporated in 2020 as a Cayman Islands exempted company and headquartered in New York, New York, the company focuses on opportunities in the healthcare industry, particularly the medical technology sector, with potential targets in the United States and internationally; it currently engages in no substantive operations and generates no revenues. The company maintains a cash position from its 2021 initial public offering of 8 million units at $10 each, raised through Class A ordinary shares and warrants, but reports no specific products or services as it has not consummated any business combination to date. No major acquisitions, mergers, partnerships, funding rounds, product launches or strategic shifts have occurred in the last 1-2 years, with the entity remaining in pursuit of a suitable target within its typical two-year post-IPO window, now extended or managed amid ongoing market conditions for special purpose acquisition companies.